✦ LIBER ✦

Aripiprazole inl-dopa-induced dyskinesias: a one-year open-label pilot study

✍ Scribed by Giuseppe Meco; Paola Stirpe; Fabrizio Edito; Carlo Purcaro; Marcella Valente; Silvia Bernardi; Nicola Vanacore

Book ID: 106207553
Publisher: Springer
Year: 2009
Tongue: English
Weight: 147 KB
Volume: 116
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-009-0231-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.279 Aripiprazole in L-Dopa induced dys

2.279 Aripiprazole in L-Dopa induced dyskinesias (LID): One year open study

✍ G. Meco; E. Fabrizio; P. Stirpe; A. Rubino; N. Vanacore 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Open-label pilot study of levetiracetam

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease

✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer

Brief Report: Effect of ambrisentan trea

Brief Report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study

✍ Saggar, Rajeev; Khanna, D.; Shapiro, S.; Furst, D. E.; Maranian, P.; Clements, P 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB